Impact of SARS-CoV2 infection on mortality and hospitalization in nursing home residents during the "Omicron era".

COVID-19 Functional status Immunization Older adults Vaccination

Journal

Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 24 02 2023
accepted: 12 04 2023
medline: 23 5 2023
pubmed: 27 4 2023
entrez: 27 4 2023
Statut: ppublish

Résumé

Widespread vaccination and emergence of less aggressive SARS-CoV2 variants may have blunted the unfavourable outcomes of COVID-19 in nursing home (NH) residents. We analysed the course of COVID-19 epidemic in NHs of Florence, Italy, during the "Omicron era" and investigated the independent effect of SARS-CoV2 infection on death and hospitalization risk. Weekly SARS-CoV2 infection rates between November 2021 and March 2022 were calculated. Detailed clinical data were collected in a sample of NHs. Among 2044 residents, 667 SARS-CoV2 cases were confirmed. SARS-CoV2 incidence sharply increased during the Omicron era. Mortality rates did not differ between SARS-CoV2-positive (6.9%) and SARS-CoV2-negative residents (7.3%, p = 0.71). Chronic obstructive pulmonary disease and poor functional status, but not SARS-CoV2 infection independently predicted death and hospitalization. Despite that SARS-CoV2 incidence increased during the Omicron era, SARS-CoV2 infection was not a significant predictor of hospitalization and death in the NH setting.

Sections du résumé

BACKGROUND BACKGROUND
Widespread vaccination and emergence of less aggressive SARS-CoV2 variants may have blunted the unfavourable outcomes of COVID-19 in nursing home (NH) residents. We analysed the course of COVID-19 epidemic in NHs of Florence, Italy, during the "Omicron era" and investigated the independent effect of SARS-CoV2 infection on death and hospitalization risk.
METHODS METHODS
Weekly SARS-CoV2 infection rates between November 2021 and March 2022 were calculated. Detailed clinical data were collected in a sample of NHs.
RESULTS RESULTS
Among 2044 residents, 667 SARS-CoV2 cases were confirmed. SARS-CoV2 incidence sharply increased during the Omicron era. Mortality rates did not differ between SARS-CoV2-positive (6.9%) and SARS-CoV2-negative residents (7.3%, p = 0.71). Chronic obstructive pulmonary disease and poor functional status, but not SARS-CoV2 infection independently predicted death and hospitalization.
CONCLUSIONS CONCLUSIONS
Despite that SARS-CoV2 incidence increased during the Omicron era, SARS-CoV2 infection was not a significant predictor of hospitalization and death in the NH setting.

Identifiants

pubmed: 37103663
doi: 10.1007/s40520-023-02415-w
pii: 10.1007/s40520-023-02415-w
pmc: PMC10134704
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1393-1399

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Références

Eur Geriatr Med. 2021 Jun;12(3):597-600
pubmed: 33891278
Cochrane Database Syst Rev. 2021 Sep 15;9:CD015085
pubmed: 34523727
Immunol Rev. 2022 Sep;310(1):27-46
pubmed: 35733376
Aging Clin Exp Res. 2021 Oct;33(10):2917-2924
pubmed: 34417733
Aging (Albany NY). 2020 Dec 22;12(24):24522-24534
pubmed: 33353888
MMWR Morb Mortal Wkly Rep. 2022 May 06;71(18):633-637
pubmed: 35511708
EBioMedicine. 2022 Jun;80:104066
pubmed: 35605428
N Engl J Med. 2022 Jul 7;387(1):21-34
pubmed: 35704396
Vaccines (Basel). 2021 Oct 13;9(10):
pubmed: 34696282
JAMA Netw Open. 2021 Mar 1;4(3):e216315
pubmed: 33787905
BMJ. 2022 Aug 2;378:e070695
pubmed: 35918098
J Am Geriatr Soc. 2021 Aug;69(8):2063-2069
pubmed: 33861873
Int J Infect Dis. 2022 Mar;116:38-42
pubmed: 34971823
Lancet Healthy Longev. 2022 May;3(5):e347-e355
pubmed: 35531432

Auteurs

Matteo Bulgaresi (M)

Geriatric Unit, Local Health Unit "Toscana Centro", Santa Maria Annunziata Hospital, Florence, Italy.

Giulia Rivasi (G)

Division of Geriatric and Intensive Care Medicine, University of Florence and Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50139, Florence, Italy. giulia.rivasi@unifi.it.

Francesca Tarantini (F)

Division of Geriatric and Intensive Care Medicine, University of Florence and Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50139, Florence, Italy.

Sofia Espinoza Tofalos (S)

Division of Geriatric and Intensive Care Medicine, University of Florence and Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50139, Florence, Italy.

Lorenzo Maria Del Re (LM)

Division of Geriatric and Intensive Care Medicine, University of Florence and Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50139, Florence, Italy.

Caterina Salucci (C)

Division of Geriatric and Intensive Care Medicine, University of Florence and Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50139, Florence, Italy.

Giada Turrin (G)

Division of Geriatric and Intensive Care Medicine, University of Florence and Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50139, Florence, Italy.

Riccardo Barucci (R)

Geriatric Unit, Local Health Unit "Toscana Centro", Santa Maria Annunziata Hospital, Florence, Italy.

Chiara Bandinelli (C)

Geriatric Unit, Local Health Unit "Toscana Centro", Santa Maria Annunziata Hospital, Florence, Italy.

Letizia Fattorini (L)

Department of Health Science, University of Florence, Florence, Italy.

Daniele Borchi (D)

Department of Health Science, University of Florence, Florence, Italy.

Marta Betti (M)

Department of Health Science, University of Florence, Florence, Italy.

Saverio Checchi (S)

Department of Health Science, University of Florence, Florence, Italy.

Lorenzo Baggiani (L)

Department of Community Healthcare Network, Health District "Toscana Centro", Florence, Italy.

Francesca Collini (F)

Quality and Equity Unit, Regional Health Agency of Tuscany, 50141, Florence, Italy.

Chiara Lorini (C)

Department of Health Science, University of Florence, Florence, Italy.

Guglielmo Bonaccorsi (G)

Department of Health Science, University of Florence, Florence, Italy.

Andrea Ungar (A)

Division of Geriatric and Intensive Care Medicine, University of Florence and Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50139, Florence, Italy.

Enrico Mossello (E)

Division of Geriatric and Intensive Care Medicine, University of Florence and Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50139, Florence, Italy.

Enrico Benvenuti (E)

Geriatric Unit, Local Health Unit "Toscana Centro", Santa Maria Annunziata Hospital, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH